Papers/PMID:22161420
Coenzyme Q10 for Parkinson's disease.
The Cochrane database of systematic reviews2011The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
coenzyme Q10 — no detected effect on withdrawal due to adverse events
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“In safety outcomes, only the risk ratios (RR) of pharyngitis (RR 1.04, 95% CI 0.18 to 5.89) and diarrhea (RR 1.39, 95% CI 0.62 to 3.16) are mild elevated between coenzyme Q10 therapy and placebo and there were no differences in the number of withdrawals due to adverse effects (RR 0.61, 95% CI 0.23 to 1.62).”
Quoted verbatim from Coenzyme Q10 for Parkinson's disease.. - Study
- meta-analysis
- Dose
- 1200 mg/d for 16 months
- Population
- patients with early and midstage Parkinson's disease; Cochrane meta-analysis of 4 RCTs, 452 patients, coenzyme Q10 versus placebo
Effect 0.61 risk ratio, 95% CI 0.23 to 1.62
Coenzyme Q10 for Parkinson's disease.2011PMID:22161420Permalink